Typical clinical uses
- Intraoral scanners and 3D imaging (CBCT)
- CAD/CAM design and milling systems
- Cloud-based dental practice and imaging platforms
- Diagnostic AI for caries / periodontal screening
- Orthodontic treatment-planning platforms
Cybersecurity for digital dentistry, intraoral scanners, and CAD/CAM.
Digital dentistry is rapidly becoming connected - intraoral scanners, CAD/CAM mills, and cloud case-design platforms all carry patient data and clinical workflows that need to be secured.
Dental imaging, CAD/CAM, and intraoral scanners increasingly stream PHI to the cloud. They are deployed in small offices that are HIPAA-covered entities but rarely have an IT or security team - so safe defaults and auto-update are part of the cybersecurity package, not an option.
Typical clinical uses
Key data flows & integrations
Case-design platforms are multi-tenant SaaS - tenant isolation and PHI handling must be designed and tested.
Scanner and CAM workstations frequently ship as un-hardened Windows.
Dental platforms are increasingly cloud-native and deployed into small offices with minimal IT. The cybersecurity history is concentrated on cloud SaaS PHI exposures and Windows-host ransomware in the supply chain.
Historical incidents
Henry Schein - a major distributor and software platform for dental practices - disclosed a cybersecurity incident in late 2023 that disrupted dental and medical distribution and software services for weeks, illustrating ecosystem dependency risk for dental device vendors.
Multiple dental practice-management and imaging SaaS vendors have disclosed PHI exposures involving misconfigured cloud storage and weak tenant isolation. These define the baseline expectation for new cloud CAD/CAM and case-design platforms.
HHS HC3 has repeatedly highlighted Windows-based imaging and management hosts in dental and small-clinic environments as a recurring ransomware entry point.
HHS HC3 sector advisories, 2022-2024
Active threat scenarios
Object-level authorization gaps across practices is a high-impact and frequent SaaS finding.
Multi-user clinic workstations without per-user authentication are a routine finding.
Windows imaging hosts on flat clinic networks are a recurring ransomware entry point.
Unaudited remote-support paths into clinics are a recurring source of unauthorized access.
What FDA reviewers cite
Dental imaging, CAD/CAM, and intraoral scanners increasingly stream PHI to the cloud - usually deployed in small offices with limited IT.
Customers rarely have an IT/security team - design defaults and update mechanisms must be safe out-of-the-box.
Modern dental workflows are cloud-native; cyber documentation must reflect that, not a legacy desktop architecture.
Dental practices are HIPAA-covered entities - your product must enable, not impede, their compliance.
What FDA scrutinizes
Customers rarely have an IT/security team - design defaults and update mechanisms must be safe out-of-the-box.
Modern dental workflows are cloud-native; cyber documentation must reflect that, not a legacy desktop architecture.
Practices are HIPAA-covered entities - the product must enable, not impede, their compliance.
Standards & deliverables
Six deliverables FDA and notified bodies expect across MedTech, with the dental-specific wrinkle on each row. Use it as a scoping checklist before you brief vendors or your QA team.
| Deliverable | Status | Cadence | Standard / guidance | Dental note |
|---|---|---|---|---|
| SBOM + VEX Machine-readable SBOM (CycloneDX/SPDX) plus VEX feed for every CVE that touches a listed component. |
Required | Premarket + monthly refresh | FDA Cybersecurity Guidance §V · CISA SBOM minimum elements | SBOM must include cloud CAD/CAM components and any imaging-host Windows dependencies. |
| Postmarket monitoring Continuous CVE / advisory monitoring against the SBOM, with a documented triage and disclosure path. |
Required | Continuous (≤30-day triage) | FD&C Act §524B · FDA Postmarket Cybersecurity Guidance | Postmarket monitoring must address ransomware-relevant components on imaging hosts. |
| Penetration test scope Black/grey-box testing across device, wireless interfaces, mobile apps, cloud APIs, and service tooling. |
Required | Premarket + on material change | AAMI TIR57 · FDA Premarket Cyber Guidance §VI.A.5 | Pen test scope: cloud CAD/CAM tenants, imaging hosts, multi-user clinic workstations. |
| Threat model STRIDE-per-interface threat model with documented mitigations and residual-risk acceptance. |
Required | Premarket, refreshed each design change | AAMI TIR57 · FDA Premarket Cyber Guidance §V.A | Model small-office IT realities - default credentials, shared workstations, USB exfiltration. |
| Secure update mechanism Signed firmware/software updates with rollback protection, integrity verification, and staged rollout. |
Required | Designed premarket, exercised lifecycle-long | FDA Cyber Guidance §IV · IEC 81001-5-1 | Out-of-the-box safe defaults and silent updates are required - no IT team to manage them. |
| Coordinated Vulnerability Disclosure Public CVD policy, intake channel, and SLAs for triage, fix, and customer communication. |
Required | Continuous, lifecycle-long | ISO/IEC 29147 + 30111 · Section 524B(b)(2) | CVD intake must be reachable by a non-technical practice manager, not only security researchers. |
Machine-readable SBOM (CycloneDX/SPDX) plus VEX feed for every CVE that touches a listed component.
Continuous CVE / advisory monitoring against the SBOM, with a documented triage and disclosure path.
Black/grey-box testing across device, wireless interfaces, mobile apps, cloud APIs, and service tooling.
STRIDE-per-interface threat model with documented mitigations and residual-risk acceptance.
Signed firmware/software updates with rollback protection, integrity verification, and staged rollout.
Public CVD policy, intake channel, and SLAs for triage, fix, and customer communication.
Many are SaMD when they make clinical claims - implant planning, orthodontic treatment planning, automated caries detection on radiographs, and similar features routinely cross the SaMD threshold. When in doubt we help you scope a Pre-Submission to FDA so the regulatory line is settled before architecture decisions lock in. The threat model and SBOM scope follow that determination, which keeps cyber effort proportional to the actual regulatory posture.
Yes when cleared as a medical device. Even when the scanner itself is low-risk hardware, the connected workflow (cloud case design, CAD/CAM mill output, EHR integration, third-party labs) typically pulls cyber into scope because the regulated indication depends on the integrity of the data moving through that pipeline. We test the device, the cloud, and the boundary between them as one connected system.
Web and API penetration testing with explicit cross-tenant authorization (BOLA) checks, plus a review of PHI handling, retention, audit logging, and key custody. We pay particular attention to the case-sharing model between dentists, labs, and specialists - that's where authorization issues most commonly surface. The architecture, data flows, and trust boundaries are documented in the threat model and traced back to specific test cases in the report.
When the workstation is part of the cleared system or the recommended configuration, OS hardening, application allowlisting, update mechanisms, and remote-access exposure all get reviewed and documented in the SPDF. End-of-life Windows on milling stations is a common finding and is addressed with compensating controls (segmentation, allowlisting, restricted services) plus a documented migration path - reviewers expect that combination, not silence on the topic.
No. HIPAA covers privacy, breach response, and the obligations of covered entities and business associates - it does not satisfy FDA premarket cybersecurity content (SPDF, threat model, SBOM, security architecture, testing) when the platform is SaMD. Both apply in parallel, and the cyber documentation has to demonstrate alignment between HIPAA controls and FDA-expected security risk management under AAMI SW96 and ISO 14971.
Each library and preset bundle is treated as a SBOM component with explicit integrity controls: signed at the source, version-pinned in the application, and verified at load time. We test the update mechanism end to end - including how a malicious or substituted library would be detected and rejected - because corrupted prosthesis presets can produce a clinically meaningful (and litigable) outcome. The chain from supplier to clinician is documented as a tamper-evident pipeline.
AI dental SaMD is treated like other AI/SaMD: the model gets supply-chain controls (signing, version pinning, load-time verification), training-data lineage is documented in the SPDF, adversarial-input testing is performed where clinically meaningful, and any PCCP describes how cyber posture is maintained across model updates. DICOM and proprietary image ingestion paths are fuzzed and authorization-tested separately from the model itself.
Yes. The lab boundary is one of the highest-risk authorization surfaces in dental software because cases routinely route to external labs and specialists with varying security postures. We model the lab as an explicit untrusted-but-authenticated party, test cross-account isolation, and document the retention and access controls that apply when a case leaves the practice tenant.
PMS/EHR integrations (HL7 v2, FHIR, vendor-specific REST) are enumerated as distinct interfaces with their own authentication, authorization, and parser-robustness tests. Where SMART on FHIR or OAuth is used we verify scope handling and token revocation. Findings here often have outsized impact because a PMS compromise can affect every case in flight.
Typical baseline: FDA 2026 final premarket cybersecurity guidance, AAMI SW96, IEC 62304 (often Class B for case-design SaMD, Class C for treatment-affecting AI), ISO 14971, OWASP ASVS for web/API, OWASP MASVS for any mobile components, plus DICOM-specific test cases for image ingestion. EU manufacturers add MDR Annex I §17.2 and MDCG 2019-16; we map artifacts across both regimes.
For a cloud SaMD case-design platform with mill/scanner integration, end-to-end premarket cyber work generally runs 5-9 weeks. Threat modeling and SBOM front-load in weeks 1-3, web/API/DICOM/integration pen testing runs in weeks 3-7, and the consolidated submission package and postmarket plan close in the final weeks. Scope and clearance-guarantee terms are confirmed in writing before kickoff.
Imaging, CAD/CAM, and intraoral scanner testing - with proportional, fixed-fee scope.

"The timeliness of this project exceeded my expectations - this was not my experience with other vendors. Blue Goat Cyber delivered a thorough, detailed report and complete testing faster than I anticipated, without compromising quality."
Cybersecurity for digital dentistry, intraoral scanners, and CAD/CAM.